Could a simple injection prevent preeclampsia? early trial begins
NCT ID NCT06924385
First seen Apr 14, 2026 · Last updated Jun 23, 2026 · Updated 12 times
Summary
This early-stage trial tested the safety and tolerability of telpegfilgrastim injections in 18 non-pregnant women, including some with a history of preeclampsia. Researchers monitored side effects, drug levels in the blood, and immune markers. The goal is to see if the drug is safe enough to study further for preventing preeclampsia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University Third Hospital
Beijin, Beijing Municipality, 100191, China
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
telpegfilgrastim injection
What this could lead to
If successful, this could point toward a treatment to prevent or manage preeclampsia in at-risk women.
What could go wrong
This is a very early Phase 1a safety study with only 18 participants, so it's too soon to know if it works. The drug may cause side effects or fail in larger trials.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.